Dudediligence.

Edgewise Therapeutics, Inc

EWTXNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$32.1M

10 notices · 1,091,382 sh

Oct 2025 to Oct 2026

Reported ·

$9,721,830

12 sales · 1 buy · $199,448 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

9 of 12 reported sales carry the 10b5-1 box. Together they are 0.31% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-13: JOANNE DONOVAN, Form 1442026-07-01: ALAN J RUSSELL, Form 1442026-05-05: JOANNE DONOVAN, Form 1442026-03-27: JOANNE DONOVAN, Form 1442026-01-21: Badreddin Edris, Form 1442026-01-20: ROBERT MICHAEL CARRUTHERS, Form 1442026-01-15: ROBERT MICHAEL CARRUTHERS, Form 1442025-12-26: ROBERT MICHAEL CARRUTHERS, Form 1442025-11-17: ROBERT MICHAEL CARRUTHERS, Form 1442025-11-12: ALAN J RUSSELL, Form 1442025-11-11: Fox Jonathan C, bought2025-11-12: Russell Alan J, sold2026-01-21: Edris Badreddin, sold2026-03-27: Donovan Joanne M., sold2026-03-31: Donovan Joanne M., sold2026-04-01: Donovan Joanne M., sold2026-05-04: Donovan Joanne M., sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-08-13JOANNE DONOVAN, CMO$127,152
2,919 shplan 2025-12-26Form 4s on file end Jun 23144 ↗
2026-07-01ALAN J RUSSELL, Chief Scientific Officer$8,126,000
200,000 shplan 2026-03-13Form 4s on file end Jun 23144 ↗
2026-05-05JOANNE DONOVAN, CMO$1,572,500
50,000 shplan 2025-12-26Form 4s on file end Jun 23144 ↗
2026-03-27JOANNE DONOVAN, CMO$2,265,760
71,588 shplan 2025-12-26144 ↗
Form 4, 2026-03-30: sold 16,358 at $30.98 Form 4 ↗
2026-01-21Badreddin Edris, Director$3,353,279
115,471 shplan 2025-09-24144 ↗
Form 4, 2026-01-23: sold 115,471 at $29.44 Form 4 ↗
2026-01-20ROBERT MICHAEL CARRUTHERS, Chief Financial Officer$5,168,722
183,867 shno plan dateno Form 4 on file144 ↗
2026-01-15ROBERT MICHAEL CARRUTHERS, Chief Financial Officer$4,804,322
180,872 shno plan dateno Form 4 on file144 ↗
2025-12-26ROBERT MICHAEL CARRUTHERS, Chief Financial Officer$3,039,812
116,665 shno plan dateno Form 4 on file144 ↗
2025-11-17ROBERT MICHAEL CARRUTHERS, Chief Financial Officer$1,566,586
70,000 shno plan dateno Form 4 on file144 ↗
2025-11-12ALAN J RUSSELL, Chief Scientific Officer$2,112,450
100,000 shno plan date144 ↗
Form 4, 2025-11-13: sold 100,000 at $21.12 Form 4 ↗